We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
(+11%)
Cap. Flow
+$734M
Cap. Flow
% of AUM
2.83%
Top 10 Holdings %
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$25.4M |
| 2 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$22.8M |
| 3 |
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
|
+$22.2M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$21.2M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$25M |
| 2 |
First Trust Value Line Dividend Fund
FVD
|
+$22.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.2M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.99% |
| 2 | Financials | 5.01% |
| 3 | Consumer Discretionary | 4.04% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCT
2551
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $363K | ﹤0.01% |
35,062
-7,306
| -17% | -$73.3K |
|
2552
Fidelity International Multifactor ETF
FDEV
$287M
| $363K | ﹤0.01% |
+13,200
| New | +$356K |
|
2553
Invesco Municipal Income Opportunities Trust
OIA
$292M
| $363K | ﹤0.01% |
55,622
+10,433
| +23% | +$66.7K |
|
|
ALE
2554
DELISTED
Allete
ALE
| $361K | ﹤0.01% |
6,049
+918
| +18% | +$53.9K |
|
2555
Brunswick
BC
$5.29B
| $361K | ﹤0.01% |
3,743
-50
| -1% | -$4.39K |
|
2556
iShares MSCI Australia ETF
EWA
$1.45B
| $361K | ﹤0.01% |
14,627
+444
| +3% | +$10.6K |
|
2557
Corbus Pharmaceuticals
CRBP
$195M
| $360K | ﹤0.01% |
+9,182
| New | +$226K |
|
2558
Franklin US Core Bond ETF
FLCB
$3.05B
| $360K | ﹤0.01% |
16,889
-68
| -0.4% | -$1.45K |
|
2559
Murphy Oil
MUR
$4.99B
| $360K | ﹤0.01% |
7,883
-1,256
| -14% | -$50.7K |
|
2560
Autoliv
ALV
$8.89B
| $359K | ﹤0.01% |
2,980
-7,185
| -71% | -$804K |
|
2561
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $359K | ﹤0.01% |
+6,400
| New | +$362K |
|
2562
InterDigital
IDCC
$8.88B
| $359K | ﹤0.01% |
3,370
+208
| +7% | +$22K |
|
2563
AllianzIM U.S. Equity Buffer20 Nov ETF
NVBW
$96.2M
| $359K | ﹤0.01% |
12,261
-1
| -0% | -$29 |
|
2564
Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO
$26M
| $358K | ﹤0.01% |
12,400
-5,130
| -29% | -$141K |
|
2565
Teladoc Health
TDOC
$1.26B
| $358K | ﹤0.01% |
23,717
+3,243
| +16% | +$58.9K |
|
2566
Robinhood
HOOD
$89.3B
| $357K | ﹤0.01% |
17,727
-834
| -4% | -$11.7K |
|
2567
Triumph Financial Inc
TFIN
$1.87B
| $357K | ﹤0.01% |
+4,506
| New | +$340K |
|
2568
Brookfield Renewable
BEP
$10.6B
| $355K | ﹤0.01% |
15,288
-91
| -0.6% | -$2.21K |
|
|
DMB
2569
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$197M
| $355K | ﹤0.01% |
34,129
+66
| +0.2% | +$679 |
|
2570
NVE Corp
NVEC
$563M
| $355K | ﹤0.01% |
+3,936
| New | +$317K |
|
2571
BlackRock Floating Rate Income Trust
BGT
$329M
| $354K | ﹤0.01% |
27,264
+3,438
| +14% | +$43.4K |
|
2572
Chemours
CC
$2.3B
| $354K | ﹤0.01% |
13,467
-643
| -5% | -$18.3K |
|
2573
Nutanix
NTNX
$18.4B
| $353K | ﹤0.01% |
5,720
-150
| -3% | -$8.65K |
|
|
PPT
2574
Franklin Premier Income Trust
PPT
$332M
| $353K | ﹤0.01% |
100,208
+446
| +0.4% | +$1.61K |
|
2575
Baker Hughes
BKR
$63B
| $352K | ﹤0.01% |
10,495
-311
| -3% | -$9.59K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
- Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
- Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
- Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
- Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
- Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
- Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.